Risk factors for medication-induced diabetes and type 2 diabetes

Shazhan Amed1, Heather Dean, Elizabeth A C Sellers

  • 1Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Children with medication-induced diabetes were less likely to have typical type 2 diabetes risk factors like obesity. This highlights the need for distinct screening and prevention strategies for medication-induced diabetes in pediatric populations.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Type 2 diabetes is increasingly diagnosed in children, often associated with obesity and family history.
  • Medication-induced diabetes is a less common but significant concern in pediatric populations.
  • Distinct risk factor profiles may exist between type 2 diabetes and medication-induced diabetes in children.

Purpose of the Study:

  • To compare the prevalence of established type 2 diabetes risk factors in children diagnosed with medication-induced diabetes versus type 2 diabetes.
  • To identify potential differences in risk factor profiles that could inform diagnosis and management.

Main Methods:

  • Retrospective observational study using data from a Canadian prospective surveillance study.
  • Comparison of clinical features and risk factors (obesity, family history, ethnicity, acanthosis nigricans, hypertension, PCOS) in new cases of type 2 diabetes (n=225) and medication-induced diabetes (n=58) over two years.
  • Descriptive statistics and logistic regression were used for comparison.

Main Results:

  • Children with medication-induced diabetes were more likely to be Caucasian (P < .0001) and less likely to be obese (P < .0001) compared to those with type 2 diabetes.
  • Medication-induced diabetes cases showed lower prevalence of positive family history of type 2 diabetes (P = .0001) and acanthosis nigricans (P < .0001).
  • Obesity-related comorbidities like PCOS (P = .04), dyslipidemia (P = .02), and hypertension (P = .04) were less common in medication-induced diabetes.

Conclusions:

  • Typical risk factors for type 2 diabetes are insufficient for identifying all children at risk for medication-induced diabetes.
  • Further research is required to develop specific screening and prevention guidelines for medication-induced diabetes in children.
  • Clinical evaluation should consider factors beyond those typically associated with type 2 diabetes when assessing children for medication-induced diabetes.
Abstract

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...